Compare MEDP & RBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | RBC |
|---|---|---|
| Founded | 1992 | 1919 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 12.6B |
| IPO Year | 2016 | 2005 |
| Metric | MEDP | RBC |
|---|---|---|
| Price | $543.83 | $444.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $465.18 | $441.17 |
| AVG Volume (30 Days) | ★ 277.0K | 165.1K |
| Earning Date | 10-22-2025 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.36 | 19.54 |
| EPS | ★ 14.32 | 8.20 |
| Revenue | ★ $2,358,373,000.00 | $1,723,400,000.00 |
| Revenue This Year | $21.48 | $14.65 |
| Revenue Next Year | $11.90 | $10.87 |
| P/E Ratio | ★ $38.28 | $54.08 |
| Revenue Growth | ★ 13.88 | 8.27 |
| 52 Week Low | $250.05 | $290.56 |
| 52 Week High | $626.26 | $449.60 |
| Indicator | MEDP | RBC |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 63.56 |
| Support Level | $530.96 | $431.72 |
| Resistance Level | $626.26 | $448.31 |
| Average True Range (ATR) | 18.24 | 10.45 |
| MACD | -8.14 | -0.71 |
| Stochastic Oscillator | 17.60 | 79.84 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
RBC Bearings Inc is an international manufacturer and marketer of engineered precision bearings, components, and essential systems for the industrial, defense, and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The company has two reportable segments: Industrial, which derives maximum revenue, and Aerospace/Defense. The Aerospace/Defense segment represents the end markets for the company's engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and the Industrial segment represents the end markets for its products used in various industrial applications. Geographically, the company generates a majority of its revenue from the United States.